RELX PLC Trading Update 2026 22nd October 2026 Transcript Disclaimer This transcript is derived from a recording of the event. Every possible effort has been made to transcribe accurately. However, neither Relx PLC nor BRR Media Limited shall be…
RELX PLC
Trading Update 2026
22nd October 2026
Transcript
Disclaimer
This transcript is derived from a recording of the event. Every possible effort has been
made to transcribe accurately. However, neither Relx PLC nor BRR Media Limited shall
be liable for any inaccuracies, errors, or omissions
Nick Luff:
Morning everyone. Thanks for joining us today. As you may have seen from
our press release this morning, we delivered strong underlying revenue
growth of 7% in the first nine months, and we continue to see positive
momentum across the group. Our improving long-term growth trajectory
continues to be driven by the ongoing shift in business mix towards high
growth analytics and decision tools that deliver enhanced value to our
customers. Turning to the performance of each business area in Risk, which
contributes about 40% of the group's profit, underlying revenue growth was
8% in line with the first half. Growth continues to be driven by our deeply
embedded AI enabled analytics and decision tools with over 90% of revenue
derived from machine-to-machine interactions. Business Services continue to
be driven by financial crime compliance and digital fraud and identity
solutions and strong new sales. Insurance continues to be driven by the
further innovation and adoption of contributing databases and market
specific solutions and strong new sales.
In STM, which contributes about a third of the group's profit, underlying
revenue growth of 6% in line with the first half and a step up from last year
as we continue on the improving long-term growth trajectory.
Databases, Tools and Electronic Reference continues to be driven by the
rollout and adoption of our AI enabled solutions built on industry leading
trusted content. LeapSpace, our recently launched research-grade AI
workspace, is receiving very positive customer feedback and is seeing rapid
usage growth. Primary Research continues to be driven by volume growth
with article submissions continue to grow very strongly for over 20% year to
date. You will hear more about the growth opportunity at STM at our
investor seminar on November 3rd. In Legal, which contributes a little over
10% of the Group’s profit, underlying revenue growth was 10% in line with
the first half and a step up from last year. Law Firms and Corporate Legal
with double digit growth continues to be driven by the adoption of our
integrated AI enabled legal research and analytics platform with its
comprehensive verified trusted content and continuously expanding agentic
capabilities.
In Exhibitions, which also contributes a little over 10% of the group's profit,
underlying revenue growth was 4%. Strong ongoing growth was moderated
by the impact of Middle East disruption of around three percentage points.
We continue to make good progress on value enhancing digital initiatives for
our customers. To summarise, we delivered strong underlying revenue
growth in the first nine months. The full year outlook is unchanged. We
expect another year of strong underlying growth in revenue and adjusted
operating profit, as well as strong growth and adjusted earnings per share on
a constant currency basis. With that, we are ready for questions.
Operator:
Thank you. We will now begin the question and answer session. To ask a
question, please press star then one on your telephone keypad. If you are
using a speakerphone, please pick up your handset before pressing the keys.
If at any time your question has been addressed and you would like to
withdraw your question, please press star then two. Your first question
comes from George Webb with Morgan Stanley. Please go ahead.
George Webb:
Yeah. Hi Nick. Morning. Just a few from my side. Firstly, just on STM with
LeapSpace maybe to start with, you kind of highlight the rapid usage growth
in today's statement. How should we be thinking about the kind of usage
versus monetisation at this stage just in terms of how you're going to
market? I guess you're trying to put these tools into as many people's hands
as you can to a certain extent. So just talking about those two things would
be great as the first question. Second question is just a confirmation. Can you
just confirm that the law firms and Corporate Legal segment of legal
continues to run at a double digit growth rate at the nine month stage year
over year? And then the third one, just on Exhibitions, when we think about
the fourth quarter and the full year in particular, what are the different
factors in there?
And maybe just also confirm that the rest of the portfolio is running maybe
at the 7% to 8% ish levels that you've previously discussed. Thank you.
Nick Luff:
Yeah. In order, George, LeapSpace. Yeah, as you say, it's been going very
well. The product's been very well received. The feedback we're getting from
customers has been very good, getting very high satisfaction. The
researchers like the outcomes they're getting, it's given them good efficiency,
saving time. I think they really value the trust that they can place in what
they get from the platform. So that is terrific. I think on usage growth, the
half year we talked about the number of users doubling in the 90 day period
from March to June. It's actually, if anything, they're going a little bit faster
than that since then. So that's why we talk about the rapid usage growth.
And to your question, obviously at this stage, our focus is primarily on user
growth and usage adoption, usage growth is adoption, et cetera. So as a
result of that, the impact on revenue is not material at this stage, but I think
we're pretty excited about the longer term opportunity.
I'm sure you'll be at the STM seminar in a couple of weeks time and we'll tell
you more about LeapSpace at that event. Your second question was on law
firms & Corporate Legal. And I did, I think, include in my opening remarks,
but just to reiterate it, it is continuing to grow at double digit. It's 70% of the
division. It's growing a little bit faster than the division and the division as a
whole, of course, is at double digit. So yes, continuing double digit. And
Exhibitions, look, exhibitions has established itself as a higher growth
business in the last few years with ongoing revenue growth in the 7% to 8%
range. And if you look at the portfolio, excluding the impacts of the Middle
East, that very much continues to be the case. Obviously there has been that
impact both from events in the region and a little bit of effect on them.We
talked about this in the first half, a little bit from the travel disruption,
including Middle East exhibitors coming to travel, particularly travel sector
related events right through to the fourth quarter. So I think the impact we
expect in the fourth quarter for the full year will be similar to what we've
seen for the year to date. But underlying as you say, I think your question
goes to the rest of the portfolio continuing to show good ongoing growth.
George Webb:
Yeah, that's great. Thank you. Thank you, Nick. And maybe just one last one
just on Exhibitions. Arabian Travel Market being one of those ones, which I
guess is quite important in the mix that maybe weighed down on that Q3
result. It looks like that's set to return next May. I mean, on one hand, I'm
kind of thinking that the base comp, so to speak, as long as it can run is
potentially softer, but wondering how you're thinking about rebooking rates
or anything like that.
Nick Luff:
I think it's too early to comment on that and look at. The key point is the one
you asked about, it's the strong ongoing growth in the portfolio is what
matters and one individual event, it tends not to be that material, but the
key is the strong ongoing growth of the portfolio as a whole.
George Webb:
Got it. Cool. Thank you, Nick.
Operator:
Thank you. Your next question comes from Nick Dempsey with Barclays.
Please go ahead.
Nick Dempsey:
Yeah, good morning, Nick. I've got a bit of a dodgy voice. Apologies if it's
slightly harder to hear me than normal, but just three for me.
Nick Luff:
Time of year.
Nick Dempsey:
First of all, in terms of the shift of legal customers to Lexis+ Protégé from the
Lexis+ platform, can you maybe give us an update on how far through that
transition is and whether that continues to run a bit faster than you saw with
previous platform upgrades? I guess what I'm getting at is when we kind of
run out of that upgrade movement. Second question, as you look at the STM
renewal environment into next year for journal subscriptions, is there
anything unusual that you're seeing or should we expect a pretty typical year
there? And then last question, there's been an allegation of bribery from a
Chinese academic against one of your cell editors in chief that Cell Cancer
editor in chief. I don't know if there anything you can say about the
investigation there and what you're doing to look into any corruption
allegations.
Nick Luff:
So the first one on Lexis+ and Protégé adoption, it's very much continued on
the same trends, the same curve that we talked about earlier in the year.
And I think we've gone over 50% adoption in the US market and a little bit
less than that than in the rest of the world with later launches. But that trend
is very much continues and continues to be the case that the vast majority of
new sales and the big majority of renewals are onto the Lexis+ Protégé
platform. And that of course is just the starting point in the people adopting
the analytics using them gives us the opportunity to keep adding more value
and the functionality and capabilities of the platform keep improving. I think
your second question was on STM, and I think you were specifically asking
about that for next year. The trends in science are very strong and you could
see in the submissions volumes that we're receiving, which obviously is the
key growth driver for the Primary Research side of STM.
We are, I think, seeing AI accelerate the pace of scientific discovery. It's
accelerating the speed at which people are able to submit. And those strong
trends mean that that's coming through in the volumes of submissions we're
getting. We of course are becoming increasingly selective and the rate of
which we're publishing isn't going up as fast as the submissions. And that's
the deliberate choice as we maintain and enhance the quality of our journal
portfolio. But the underlying drivers, the amount of research going on in the
world, the amount of speed of submission, et cetera, are very strong and
don't see anything that looks like it'll change that.
And your last question was about publishing ethics and research integrity.
Obviously that's absolutely crucial to the whole scientific publication process
and Elsevier's quality and reputation and the reputation of its journal is
absolutely key. We are committed to the highest standards of publishing
ethics and we've got well established procedures to make sure we maintain
the quality and the integrity. And of course, concerns around research
integrity is one of the reasons authors can choose established trusted brands
that have got the track record, which of course are the ones that we have.
And of course no process is perfect and if there are concerns raised, we will
investigate them. I won't comment on any individual case of course, but we
would investigate anything. And I would just reiterate that our retraction rate
is incredibly low, a fraction of 1%. So the process is robust and I think people
have confidence in the quality of what we publish.
George Webb:
Thanks Nick
Nick Luff:
Great. Thanks.
Operator:
Thank you. Your next question comes from Steve Liechti with Deutsche
Numis. Please go ahead.
Steve Liechti:
Yeah, morning. I've got a few. Just on Academic, just taking a very sort of
strategic, non-specific view, do you see any merit in adding to or doing M&A
in your Primary Research side? Because your M&A historically has been
much more skewed towards technology and tools. Is there a kind of scale
argument? That's the first question. Second question is, can you just a couple
of numbers on submissions? Are you able to give us an OA submissions
number on the nine months? And also just confirm, I think your articles
published 7% at the first half. Is that a similar figure for the nine months?
And then the final one, just a general one actually, just on virtual AI
assistants, Muse and stuff like that. I'm trying to figure out what that means
for you. I mean, I can see a positive argument in that more AI led virtual
assistants, more activity in digital, more need for verification.
But on the other hand, would an AI virtual assistant be verified and therefore
less work for you to do? Just any colour there. Thanks.
Nick Luff:
Yeah. I'll take those in order Steve. The first one was the M&A in STM. As
with all of our business, of course, our focus primarily is in organic
development, you’ve seen the volume growth that we're getting. And so
there's plenty of drivers of the growth organically. That includes, of course,
launching new journals. We launch dozens of new journals every year as we
fill in gaps in the portfolio, expanding to new disciplines and expanding
disciplines, launching new OA journals in particular. And of course we've
already got the scale, comfortably the number one scientific publisher in the
world already got the scale, which gives us the resources to put behind that
business, invest in the technology, make sure we've got the scales to the
tools using AI, of course, to support the whole publication process. And we'll
tell you more about that at the STM seminar in a couple of weeks' time.
As elsewhere in the group, we'd always look at acquisitions as a way of
enhancing and accelerating what we do, and we do occasionally buy specific
journals or small groups of journals that fit into the portfolio. But the primary
focus is on the organic development. Your same questions about open access
submissions and so on, but they are open access volumes on an author pays
basis. Those are both submissions and publication volumes are higher than
the overall average, and that continues to be the case. And there's been no
change in that trend. Both are growing, both pay to read and pay to publish,
just pay to publish growing faster, which is what's shifting the mix. The
overall published volumes, as you mentioned, I think we said 7% growth at
the first half. There's been no change in that sort of pace, maybe a point
either way, but no significant change in the pace at which we're publishing.
And your third question was on agents and the like, by use by consumers. I
think it's fair to say that we're still at the early stages of our customers, the
banks and the retailers and other customers of ours. I think early stages them
interacting with agents that are acting on behalf of consumers. We're already
helping them detect agentic activity and helping them adjust their risk
controls so we can help our customer identify when an AI agent is involved,
how it's behaving, how it relates to the consumer that's behind the agent,
and incorporate those insights into the risk decisions, effectively whether to
trust the transaction or whether to require more authentication. But I think
it's fair to say that it's still pretty early days. What I would say is that agents,
of course, the use of agents just creates more complexity, potentially higher
interaction volumes, we'll see.
But that overall complexity and potentially higher volumes does give us the
opportunity to find new ways to add value for the customers.
Steve Liechti:
Great. Thank you.
Nick Luff:
Thanks, Steve.
Operator:
Thank you. Your next question comes from Kieran Donnley with Citi. Please
go ahead.
Kieran Donnley:
Yeah, thanks, Nick. One left from me, just on Legal and the competitive
space, one of your peers has been increasingly talking about developing
capabilities in the legal research space. So I think one, could you just outline
whether you've seen any change in competitive dynamics within that
market? And two, just remind us about the difficulty of replicability of the
Lexis solution and database. Thanks.
Nick Luff:
Yeah. Well, clearly, as you know, our whole strategy across the group,
including Legal, does start with our differentiated comprehensive content,
verified, trusted, continuously updated, and then how we leverage the
domain expertise we have to combine that content with the analytics and
the functionality and the tools. The content set in legal consists of billions of
documents. I've shown you some of this in some of our seminars, but billions
of documents which we've collected and curated over decades. It is
continuously updated from over 3,000 courts and tens of thousands of other
sources. And within the content set, there's something like 170 billion
linkages and connections that are obviously critical to be able to utilise it in
the whole content set in an effective way. We enrich through editorial
metadata enhancements, use of technology, use of the. We have over 5,000
leading practitioners and subject matter experts in the law, and that's what
makes the content set so powerful and so important in the legal research
space.
Of course, it is possible for others to access specific content sets, for
example, US case law that's currently available publicly. Several players have
had that and been collecting that for many years, but that is only a small part
of what we do. And for high value legal research where you need to be very
confident that you're making the right arguments, the best arguments, that
everything you're citing is up to date, hasn't been overturned, and you're
going into the high stakes, going into court tomorrow, you need that vast,
trusted, curated content set that we have.
Kieran Donnley:
And just on any change in competitive dynamics in that space specifically?
Nick Luff:
All I can comment on is how our business is doing and you have seen the
continued growth rate in our Legal business with its overall double digit
growth and customers overwhelmingly continue to choose our integrated AI
platform. And you can see that in the new sales, which I mentioned earlier in
the renewals, and that's where they're seeing value. So that's what we see in
the marketplace.
Kieran Donnley:
Great, thanks.
Operator:
Thank you. Your next question comes from Will Packer with BNPP. Please go
ahead.
Will Packer:
Hi there
Thank you for taking my question. So we're seeing a rapidly evolving legal
workflow market with Astra for law, from OpenAI, Gemini, Gemini for legal
from Google, Claude Legal, et cetera, as well as the developments of Harvey
and Legora. So we're seeing quite different strategies from the Clios, the
Westlaws, the LexisNexis’ in terms of integrating their research content into
that orchestration layer. Lexis from the outside appears to be most cautious
on integration in those third party workflows. Could you help us think
through the key strategic considerations as you develop your strategy on
integrating with those new workflows, which one would imagine are getting
more and more important? On first principles, it would feel that maximum
integration would be the client's preference, but perhaps that's wrong. Any
colour there would be very helpful. Thank you.
Nick Luff:
Yeah, just to reiterate, obviously our starting point in this is, as I just
mentioned, and where our strategy is based in, is that trusted, differentiated,
comprehensive content set that we were just talking about and adding the
functionality, the capabilities and the tools, et cetera, around that. We do
that on our own platform. We also do that through partnerships and
integrations that we have with others. We've talked about this in the past
with. We have something like 25 different partnerships and integrations.
They include things like Microsoft, of course, where a lot of lawyers work in
Microsoft and we've announced new ones just in the last quarter. And of
course we utilise, as you know from previous presentations, how we utilise
all the different large language models and have a deliberate technology
agnostic multi-model approach to make sure we're using the right ones. And
our objective is to provide the functionality and interoperability that our
customers find valuable.
So we always evaluate every new tool that comes out, every new piece of
functionality and assess whether the best thing and the best way to utilise
that and provide value to customers in the context of what we do for them,
whether it's to replicate that functionality, whether it's to build it into our
platform or whether to enable that interoperability between products. Our
focus tends to be on the substance, on exactly that, what value can we add
to the customers taking feedback from the customers, and we'll continue to
take that approach and building the interoperability and the integrations that
we think our customers will find most valuable.
Will Packer:
So it sounds like your approach is kind of more pragmatic and agile, be a fair
characterisation?
Nick Luff:
Yeah, you might have seen just this quarter we announced the setting up of
our innovation lab, which is an environment where we're bringing in legal
professionals from law firms, from corporate to work directly with LexisNexis
product developers, the LexisNexis engineers, taking their feedback real time
and working on things that problem areas or opportunities for efficiency that
they're feeding back to us and looking at how they work in practise. So it's
not about press releases and announcements, it's about real practical tools
and functionality and that interoperability that the actual end users find
valuable.
Will Packer:
Thanks for the colour.
Operator:
Thank you. Your next question comes from Natale Puccia with TD Cowen.
Please go ahead.
Natale Puccia:
Hi there. Good morning. Thanks for taking my question. So obviously Legal
has continued to grow well above its historical rate as AI enabled products
have scaled. Maybe could you just help us understand qualitatively how
much of the incremental growth today is being driven by AI enabled products
and higher customer value versus the underlying core research business?
And perhaps maybe briefly on STM. I don't want to steal any of your thunder
from the upcoming seminar, but I know monetisation perhaps is a bit of a
longer path, but does the value from these AI tools, do you believe they'll
show up principally through higher ARPU within existing customers or I
suppose through expansion of the addressable market? Thank you.
Nick Luff:
Yeah, your first question about the revenue and how much from AI enabled. I
mean, of course it's very hard to separate it because this is absolutely
integrated into the platform, the core flagship platform in Legal. Lexis+ with
Protégé, of course, is fundamentally built on the legal research platform and
then adding the agent capabilities and the functionality on top of that. I
think, as I mentioned earlier, the vast majority of new sales and majority of
renewals are onto that platform. As we've discussed in the past, there is an
uplift in spend when someone moves to that platform compared to the older
platform. So obviously that's an important component of the overall growth
and the acceleration of the growth we've seen in recent years, but I can't
separate it out in the sense of perhaps that you're looking for. It's just overall
value and overall revenue growth being driven by the provision of that value.
Your other question about STM, as you say, I won't steal thunder for two
weeks, it's less than two weeks away till the STM seminar and should talk a
bit more about this there. I think it's true that with STM having a more
diverse product suite with a broader range of use cases, a broader range of
customers, some of those customers do have longer decision making cycles.
Obviously it is a large subscription based business too. So changes and the
benefits of adoption of new tools comes through gradually into growth rates
over time, and that's fine. We do see significant opportunity of the
application of generative AI and other new technologies in the scientific and
healthcare space, and specifically in relation to what we do. We think that
creates more value, significantly more value for customers who utilise our
products as we build that functionality and capability in.
And overall, over time, that value is reflected in our revenues and that's what
is the key growth driver. And as you say, we'll talk about that more at the
seminar.
Natale Puccia:
That's great. Thank you.
Operator:
Thank you. Your next question, pardon me. If you wish to ask a question,
please press star then one on your telephone keypad. We'll now pause a
moment to allow for any further Questions to register. Once again, that is
star one. Your next question comes from Adam Berlin with Goldman Sachs.
Please go ahead.
Adam Berlin:
Hi, good morning, Nick.
Nick Luff:
Hi, Adam.
Adam Berlin:
Two from me, please. The first question is following up on the discussion
around Muse earlier. You said it was a bit early, but one obvious application
would be people using Muse to search car insurance quotes to see if they can
search maybe 20 to 30 cost insurers rather than just one or two online. Have
you seen any impact there from people using that application yet? Because
that might be something you have seen in a couple of months since Muse
has gone live. That's the first question. The second question is, when you say
that Protégé platform has got over 50% penetration, do you mean that the
number of law firms is more than 50% or the number of users is more than
50%? Thanks.
Nick Luff:
Yeah. On your first question about insurance volumes, I think it's fair to say
as of yet, there's no noticeable. Bear in mind, the numbers are vast and
we're potential all US consumers, all US car owners and drivers. So the
number who might be using an agent to do shopping for them does remain a
small fraction of that at this stage. But as you rightly say, Adam, clearly there
is potential for higher volumes of activity. The overall insurance market
activity hasn't particularly changed. It remains elevated as the market we've
seen higher volumes in the last couple of years. It continued at higher levels,
but we'll see where it goes from here. Just to reiterate, of course, the key
driver for us is the innovation and not necessarily the volumes themselves
will vary over time, but it's actually for us, it's about the innovation, new
functionality, new products potentially based around and related to the use
of agentic consumers using agents, but we'll see how that evolves.
And your second question was about Lexis+ with Protégé. When we talk
about the base and being over half now in the US on the new platform,
Lexis+ Protégé, we're just weighting that by revenue, the revenue mix of the
overall business.
Adam Berlin:
Okay. Thanks, Nick.
Operator:
Thank you. Your next question, it comes from Henry Hayden with Rothschild
& Co Redburn. Please go ahead.
Henry Hayden:
Yeah, morning, Nick. Thanks for taking our questions. There's some new
language in the release around LeapSpace, which seems from our end to be a
very positive development. We were wondering if you could share some
thoughts around the risk of that solution cannibalising Scopus AI and
ScienceDirect AI given the overlaps in functionality. Secondly, strong new
sales in fraud and ID again. We were hoping you could give us an update on
the state of under penetration in that market, given that this has been a
recurring piece of language, particularly against the accelerating backdrop of
agentic fraud. So in other words, is the market growing faster than it can be
sold into? And then finally, we're hoping for an update on the difficult comps
in all those transactional volumes. Are you seeing those already come
through against that 8% growth figure and how should we think about that
trajectory into next year?
Thank you.
Nick Luff:
Yes. Sorry Henry, I didn't quite catch your second question. What was the
topic?
Henry Hayden:
On the state of under penetration in fraud and ID, just is the market growing
faster than you can sell new solutions into it.
Nick Luff:
Okay. Yeah, your first question about LeapSpace and Scopus and
ScienceDirect AI, I will slightly defer to the STM seminar in a couple of weeks'
time. Scopus does serve a different use case and does slightly different things
and we can talk a bit more about that at the seminar. And that continues to
go well as a product that's on similar trends to what we saw earlier in the
year. On ScienceDirect AI, that product has effectively been wrapped up into
LeapSpace. LeapSpace is a successor product to ScienceDirect AI. So users
and customers who'd bought ScienceDirect AI have been migrated to
LeapSpace and that's the next generation with all the additional functionality
and things that come with that. And again, we'll talk about that at the
seminar.
On Fraud and Identity, obviously that's the Business Services of which the
fraud and identity is just over a third of that in terms of that segment within
Risk, alongside Financial Crime Compliance being the other big part of it, of
that particular segment. It's been an important growth area for a number of
years, continues to be. It is where we are seeing lots of opportunity to
continue to innovate, continue to bring new features, new functionality. It's
where we've moved from identity being about the person and the individual
to still being about that of course, but also being about the device that
they're using.
Also about how they use that device, so-called behavioural biometrics,
document authentication, which is related to that. And we talked in the
seminar on Business Services back in May about IDverse, which was a
functionality that got through an acquisition that we've integrated into the
platform. So continuing to see lots of opportunity and of course with GenAI
being used by the bad guys as it were, that does create new challenges for
our customers, meaning when you get synthetic IDs and deepfakes and so
on. And therefore the importance of what we do becomes all the greater and
we continue to see strong demand for the F&I products, Fraud and Identity
products with expanding use cases and us adding new functionality as we
help customers combat those emerging threats. And your last question was
on auto insurance volumes. I think, again, I'd reiterate that the key growth
driver in Risk as a whole and insurance is the innovation.
It is coming from the introduction and rollout of new products and new
features that continues at pace and that's what's really driving the consistent
high single digit growth that you're seeing in Risk. Of course, we do have
some volumetric pricing, particularly in Insurance. So the volumes that go to
the platform are relevant to us, but they tend to even out across the
different segments. Insurance volumes do remain high, shopping and
switching activity. They grew quite strongly over the last couple of years, so
we're not seeing quite the same growth that we're seeing, but they do
remain high. But if you combine that with what we're seeing in the Business
Services and look at Risk as a whole, the different range of factors that
influence the transaction volumes, they do typically balance out over time
and that's why you've seen the consistency in the overall growth rate driven
primarily by the innovation.
Henry Hayden:
Very helpful. Thank you.
Operator:
Thank you. This concludes our question and answer session. I would now like
to turn the conference back over to Nick for any closing remarks.
Nick Luff:
Okay. Thank you everyone for joining us today and thanks for your questions.
And just if I haven't mentioned it enough times already, we have a seminar
on STM in a couple of weeks' time, which we'll see you at that. Thank you.